These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1468084)
1. Third-generation cephalosporins: a review. Cunha BA Clin Ther; 1992; 14(5):616-52; discussion 615. PubMed ID: 1468084 [TBL] [Abstract][Full Text] [Related]
2. [Review of oral cephalosporins. Basis for a rational choice]. Forti IN Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980 [TBL] [Abstract][Full Text] [Related]
3. Symposium on antimicrobial therapy. IV. The cephalosporins. Greenfield RA J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review. Bijie H; Kulpradist S; Manalaysay M; Soebandrio A J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439 [TBL] [Abstract][Full Text] [Related]
5. The selection and use of cephalosporins: a review. Klein NC; Cunha BA Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation. Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Drieux L; Brossier F; Sougakoff W; Jarlier V Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
10. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. Urbánek K; Kolár M; Lovecková Y; Strojil J; Santavá L J Clin Pharm Ther; 2007 Aug; 32(4):403-8. PubMed ID: 17635342 [TBL] [Abstract][Full Text] [Related]
11. Cephalosporins: rationale for clinical use. Molavi A Am Fam Physician; 1991 Mar; 43(3):937-48. PubMed ID: 2000736 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476 [TBL] [Abstract][Full Text] [Related]
14. The role of newer antibiotics in gastroenterology. Li E; Stanley SL Gastroenterol Clin North Am; 1992 Sep; 21(3):613-29. PubMed ID: 1516960 [TBL] [Abstract][Full Text] [Related]
15. Cefepime: the next generation? Sanders CC Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678 [TBL] [Abstract][Full Text] [Related]
16. Cefepime: a new fourth-generation cephalosporin. Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411 [TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital. Graffunder EM; Preston KE; Evans AM; Venezia RA J Antimicrob Chemother; 2005 Jul; 56(1):139-45. PubMed ID: 15917283 [TBL] [Abstract][Full Text] [Related]
19. [Effect of broad spectrum beta-lactamases on in vitro sensitivity of clinical isolates of Klebsiella pneumoniae to oral cephalosporins]. Bedenić B; Singer S Lijec Vjesn; 2000; 122(1-2):8-13. PubMed ID: 10916350 [TBL] [Abstract][Full Text] [Related]